What is Manhattan Associates Inc's earnings per share (EPS)?

Manhattan Associates Inc (MANH) reported diluted earnings per share of $3.60 for fiscal year 2025. This represents a 2.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Manhattan Associates (MANH) Financials

MANH NASDAQ

Trailing 12 months to June 30, 2026

Revenue $1.1B +6.5% YoY

Net Income $210.2M -4.9% YoY

EPS (Diluted) $3.48 -2.8% YoY

Free Cash Flow $399.2M +29.9% YoY

Market Cap $13.8B as of Oct 26, 2026

Price / Sales 12.2x on $1.1B revenue, trailing 12 months to June 30, 2026

Price / Earnings 65.6x on $210.2M net income, trailing 12 months to June 30, 2026

Price / Book 87.5x on $157.5M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 31, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MANH SEC filings page.

Manhattan Associates Inc (MANH) reported $1.1B in revenue over the twelve months to Jun 30, 2026, up 6.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MANH FY2025 2026-10-25

Manhattan Associates converts modest FY2025 growth into wider margins and unusually strong cash generation, despite slower bottom-line growth.

FY2025’s cash conversion widened: operating cash flow rose 32.0% while net income rose 0.7%. Operating cash flow was 177.1% of net income, indicating that non-earnings items or working-capital timing, rather than profit growth alone, powered much of the cash improvement.

FY2025’s margin expansion reflects revenue growing faster than direct costs: revenue increased 3.7% while cost of revenue rose only 0.3%. Gross margin reached 56.3%, but net income increased just 0.7%. Income-tax expense rose 36.1%, limiting how much operating improvement reached net income.

Capital needs remain modest: free cash flow reached $374M despite capital expenditures rising 78.2%. Capex was still only 1.4% of revenue, while share buybacks totaled $315M; this pairing shows cash being directed more toward shareholder distributions than physical reinvestment.

Financial Health Signals

Financial Health Score 67/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Manhattan Associates Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Manhattan Associates Inc has an operating margin of 25.9%, meaning the company retains $26 of operating profit per $100 of revenue. This strong profitability earns a score of 88/100, reflecting efficient cost management and pricing power. This is up from 25.1% the prior year.

Growth

Manhattan Associates Inc's revenue grew a modest 3.7% year-over-year to $1.1B. This slow but positive growth earns a score of 59/100.

Leverage

Liquidity

Manhattan Associates Inc's current ratio of 1.28 indicates adequate short-term liquidity, earning a score of 33/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Manhattan Associates Inc converts 34.6% of revenue into free cash flow ($374.0M). This strong cash generation earns a score of 94/100.

Returns

Manhattan Associates Inc earns a strong 69.9% return on equity (ROE), meaning it generates $70 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 95/100. This is down from 73.0% the prior year.

Altman Z-Score Safe

18.91

Manhattan Associates Inc scores 18.91, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $13.8B against total liabilities of $524.6M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

6/8

Manhattan Associates Inc passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality Cash-Backed

1.77x

For every $1 of reported earnings, Manhattan Associates Inc generates $1.77 in operating cash flow ($389.5M OCF vs $219.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$297.8M

YoY+9.3%

QoQ+5.5%

5Y CAGR+12.4%

10Y CAGR+6.8%

Manhattan Associates Inc generated $297.8M in revenue in Q2 2026. This represents an increase of 9.3% from the same quarter a year earlier. Against the prior quarter it is up 5.5%.

EBITDA

$67.9M

YoY-10.0%

QoQ+1.6%

5Y CAGR+10.4%

10Y CAGR+2.2%

Manhattan Associates Inc's EBITDA was $67.9M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 10.0% from the same quarter a year earlier. Against the prior quarter it is up 1.6%.

Net Income

$50.4M

YoY-11.3%

QoQ+2.1%

5Y CAGR+10.5%

10Y CAGR+4.2%

Manhattan Associates Inc reported $50.4M in net income in Q2 2026. This represents a decrease of 11.3% from the same quarter a year earlier. Against the prior quarter it is up 2.1%.

EPS (Diluted)

$0.85

YoY-8.6%

QoQ+3.7%

5Y CAGR+12.1%

10Y CAGR+6.3%

Manhattan Associates Inc earned $0.85 per diluted share (EPS) in Q2 2026. This represents a decrease of 8.6% from the same quarter a year earlier. Against the prior quarter it is up 3.7%.

Cash & Balance Sheet

Free Cash Flow

$89.7M

YoY+28.0%

QoQ+12.2%

5Y CAGR+14.8%

10Y CAGR+18.2%

Manhattan Associates Inc generated $89.7M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 28.0% from the same quarter a year earlier. Against the prior quarter it is up 12.2%.

Cash & Debt

$186.1M

YoY-19.3%

QoQ-17.7%

5Y CAGR-2.3%

10Y CAGR+7.2%

Manhattan Associates Inc held $186.1M in cash as of Q2 2026; no long-term debt figure is on record for that period.

Shares Outstanding

58M

YoY-3.6%

QoQ-1.5%

5Y CAGR-1.7%

10Y CAGR-2.0%

Manhattan Associates Inc had 58M shares outstanding in Q2 2026. This represents a decrease of 3.6% from the same quarter a year earlier. Against the prior quarter it is down 1.5%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

56.5%

YoY-0.8pp

QoQ+1.4pp

5Y change-0.9pp

Manhattan Associates Inc's gross margin was 56.5% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.4 percentage points.

Operating Margin

22.2%

YoY-4.8pp

QoQ-0.8pp

5Y change-1.5pp

10Y change-11.5pp

Manhattan Associates Inc's operating margin was 22.2% in Q2 2026, reflecting core business profitability. This is down 4.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.

Net Margin

16.9%

YoY-3.9pp

QoQ-0.6pp

5Y change-1.5pp

10Y change-4.6pp

Manhattan Associates Inc's net profit margin was 16.9% in Q2 2026, showing the share of revenue converted to profit. This is down 3.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.6 percentage points.

Return on Equity

32.0%

YoY+11.6pp

QoQ+7.9pp

5Y change+17.6pp

10Y change+12.9pp

Manhattan Associates Inc's quarterly ROE was 32.0% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is up 11.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 7.9 percentage points.

Capital Allocation

R&D Spending

$34.8M

YoY-0.3%

QoQ-6.9%

5Y CAGR+8.4%

10Y CAGR+10.0%

Manhattan Associates Inc invested $34.8M in research and development in Q2 2026. This represents a decrease of 0.3% from the same quarter a year earlier. Against the prior quarter it is down 6.9%.

Share Buybacks

$127.1M

YoY+153.2%

QoQ-29.2%

5Y CAGR+30.9%

10Y CAGR+13.8%

Manhattan Associates Inc spent $127.1M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 153.2% from the same quarter a year earlier. Against the prior quarter it is down 29.2%.

Capital Expenditures

$1.0M

YoY-74.7%

QoQ-75.5%

5Y CAGR+10.8%

10Y CAGR-7.5%

Manhattan Associates Inc invested $1.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 74.7% from the same quarter a year earlier. Against the prior quarter it is down 75.5%.

MANH Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MANH quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$1.1B	$1.1B+3.7%	$1.0B+12.2%	$928.7M+21.1%	$767.1M+15.6%	$663.6M+13.2%	$586.4M-5.1%	$617.9M+10.5%	$559.2M-6.0%	$594.6M-1.6%	$604.6M+360.4%	$131.3M-2.5%	$134.6M+21.5%	$110.8M+6.1%	$104.4M+15.1%	$90.7M
Cost of Revenue	$497.7M	$472.3M+0.3%	$471.0M+9.4%	$430.6M+20.2%	$358.2M+20.3%	$297.8M+10.4%	$269.9M-5.3%	$285.0M+18.3%	$240.9M-2.0%	$245.7M-1.7%	$249.9M+6.1%	$235.4M+10.7%	$212.6M+17.3%	$181.2M+12.0%	$161.7M+16.3%	$139.1M
Gross Profit	$628.5M	$609.1M+6.6%	$571.4M+14.7%	$498.1M+21.8%	$408.8M+11.8%	$365.8M+15.6%	$316.5M-5.0%	$333.0M+4.6%	$318.3M-8.8%	$348.9M-1.6%	$354.7Mn/m	-$104.1Mn/m	-$78.0Mn/m	-$70.4Mn/m	-$57.3Mn/m	-$48.4M
R&D Expenses	$147.0M	$145.1M+5.4%	$137.7M+8.6%	$126.8M+13.4%	$111.9M+14.6%	$97.6M+15.8%	$84.3M-3.8%	$87.6M+21.9%	$71.9M+24.6%	$57.7M+5.4%	$54.7M+1.6%	$53.9M+10.0%	$49.0M+9.9%	$44.5M-0.3%	$44.7M+5.5%	$42.4M
SG&A Expenses	$192.6M	$174.9M+5.5%	$165.8M+6.5%	$155.7M+13.1%	$137.6M+9.3%	$125.9M+15.3%	$109.2M-10.1%	$121.5M+16.9%	$103.9M+11.1%	$93.5M-3.1%	$96.5M-1.4%	$97.9M+0.8%	$97.1M+18.8%	$81.7M-2.8%	$84.1M+3.0%	$81.7M
Operating Income	$274.0M	$279.8M+7.0%	$261.6M+24.6%	$209.9M+37.4%	$152.7M+13.7%	$134.3M+17.8%	$114.1M-1.6%	$115.9M-13.4%	$133.9M-27.9%	$185.6M-4.5%	$194.3M+20.4%	$161.4M+27.0%	$127.1M+25.5%	$101.3M+26.5%	$80.1M+30.5%	$61.4M
EBITDA	N/A	$286.1M+6.8%	$267.9M+24.2%	$215.6M+35.3%	$159.4M+12.0%	$142.2M+15.6%	$123.0M-0.7%	$123.9M-13.0%	$142.5M-26.8%	$194.7M-4.3%	$203.4M+20.2%	$169.2M+26.7%	$133.5M+24.6%	$107.1M+25.0%	$85.7M+24.9%	$68.6M
Income Tax	$73.1M	$65.9M+36.1%	$48.5M+30.6%	$37.1M+27.2%	$29.2M+23.6%	$23.6M-11.1%	$26.5M-12.5%	$30.3M-3.9%	$31.5M-53.9%	$68.4M-4.9%	$71.9M+21.1%	$59.4M+29.1%	$46.0M+28.4%	$35.8M+22.7%	$29.2M+59.3%	$18.3M
Net Income	$210.2M	$219.9M+0.7%	$218.4M+23.7%	$176.6M+36.9%	$129.0M+16.7%	$110.5M+26.6%	$87.2M+1.7%	$85.8M-18.1%	$104.7M-10.1%	$116.5M-6.2%	$124.2M+20.1%	$103.5M+26.2%	$82.0M+21.8%	$67.3M+29.8%	$51.9M+15.5%	$44.9M
EPS (Basic)	N/A	$3.64+2.2%	$3.56+24.5%	$2.86+39.5%	$2.05+17.8%	$1.74+27.0%	$1.37+3.0%	$1.33-15.8%	$1.58-6.0%	$1.68-2.9%	$1.73+22.7%	$1.41+29.4%	$1.09+23.9%	$0.88	$0.66+20.0%	$0.55
EPS (Diluted)	$3.48	$3.60+2.6%	$3.51+24.5%	$2.82+38.9%	$2.03+18.0%	$1.72+26.5%	$1.36+3.0%	$1.32-16.5%	$1.58-6.0%	$1.68-2.3%	$1.72+22.9%	$1.40+29.6%	$1.08+25.6%	$0.86	$0.64+23.1%	$0.52
Diluted Shares (Avg)	N/A	61M-1.8%	62M-0.7%	63M-1.3%	63M-1.4%	64M0.0%	64M-1.2%	65M-2.0%	66M-4.3%	69M-3.7%	72M-2.7%	74M-2.4%	76M-2.7%	78M	81M-5.7%	86M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$297.8M+9.3%	$282.2M+7.4%	$270.4M+5.7%	$275.8M+3.4%	$272.4M+2.7%	$262.8M+3.2%	$255.8M+7.4%	$266.7M+11.8%
Cost of Revenue	$129.5M+11.4%	$126.6M+10.5%	$121.7M+7.7%	$119.8M+1.0%	$116.2M-3.2%	$114.6M-4.0%	$113.0M+5.9%	$118.7M+6.5%
Gross Profit	$168.3M+7.8%	$155.6M+5.0%	$148.6M+4.1%	$156.0M+5.4%	$156.2M+7.5%	$148.2M+9.6%	$142.8M+8.6%	$148.0M+16.6%
R&D Expenses	$34.8M-0.3%	$37.3M+5.8%	$38.5M+16.8%	$36.4M+5.9%	$34.9M-1.3%	$35.3M+0.8%	$33.0M+5.3%	$34.3M+3.8%
SG&A Expenses	$57.4M+25.0%	$51.5M+13.6%	$41.6M-12.5%	$42.1M+14.2%	$46.0M+14.1%	$45.3M+10.1%	$47.5M+19.3%	$36.9M-5.5%
Operating Income	$66.2M-10.2%	$64.9M+2.8%	$67.0M+10.4%	$75.8M+1.0%	$73.8M+8.2%	$63.2M+9.6%	$60.7M+3.1%	$75.1M+40.5%
EBITDA	$67.9M-10.0%	$66.8M+3.2%	$68.5M+10.0%	$77.5M+0.9%	$75.4M+8.2%	$64.7M+9.5%	$62.3M+3.2%	$76.8M+39.9%
Income Tax	$16.9M-4.9%	$20.0M+67.5%	$16.5M+12.5%	$19.8M+56.9%	$17.7M+8.5%	$11.9M+147.2%	$14.7M+33.4%	$12.6M+118.9%
Net Income	$50.4M-11.3%	$49.3M-6.3%	$52.0M+8.2%	$58.6M-8.1%	$56.8M+7.6%	$52.6M-2.3%	$48.0M-1.5%	$63.8M+29.1%
EPS (Basic)	$0.86-8.5%	$0.83-3.5%	$0.87+10.1%	$0.97-6.7%	$0.94+9.3%	$0.86-1.1%	$0.790.0%	$1.04+30.0%
EPS (Diluted)	$0.85-8.6%	$0.82-3.5%	$0.85+10.4%	$0.96-6.8%	$0.93+9.4%	$0.85-1.2%	$0.770.0%	$1.03+30.4%
Diluted Shares (Avg)	59M-3.4%	60M-2.4%	N/A	61M-1.6%	61M-1.7%	62M-1.5%	N/A	62M-0.6%

Not reported in any period shown, so not listed: Interest Expense.

MANH Balance Sheet

MANH quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$839.4M+10.8%	$757.6M+12.5%	$673.4M+18.1%	$570.2M+5.6%	$539.7M+16.0%	$465.4M+25.0%	$372.3M+21.2%	$307.1M-2.5%	$315.0M+6.0%	$297.1M-10.6%	$332.2M+4.4%	$318.2M+6.8%	$297.8M+13.8%	$261.8M+0.9%	$259.6M
Current Assets	$583.3M+15.9%	$503.3M+5.0%	$479.2M+15.4%	$415.4M+1.7%	$408.4M+22.3%	$334.0M+44.0%	$232.0M+7.7%	$215.4M-5.6%	$228.1M+10.2%	$207.0M-12.6%	$236.9M+3.1%	$229.9M+5.1%	$218.7M+20.5%	$181.5M+4.0%	$174.5M
Cash & Equivalents	$328.7M+23.5%	$266.2M-1.7%	$270.7M+20.1%	$225.5M-14.5%	$263.7M+28.8%	$204.7M+85.0%	$110.7M+11.7%	$99.1M-21.0%	$125.5M+31.3%	$95.6M-19.3%	$118.4M+2.3%	$115.7M-7.0%	$124.4M+28.6%	$96.7M+4.9%	$92.2M
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0-100.0%	$1.4Mn/m	$0n/m	$0-100.0%	$10.3M+18.5%	$8.7M+1.7%	$8.6M+36.0%	$6.3M+3.8%	$6.1M
Accounts Receivable	$214.7M+4.5%	$205.5M+13.4%	$181.2M+8.6%	$166.8M+34.0%	$124.4M+13.9%	$109.2M+8.2%	$100.9M+0.8%	$100.1M+8.5%	$92.2M-8.0%	$100.3M+3.0%	$97.4M+12.2%	$86.8M+22.1%	$71.1M+14.5%	$62.1M+10.4%	$56.3M
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0-100.0%	$855K
Goodwill	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.3M0.0%	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.3M0.0%	$62.3M0.0%	$62.3M0.0%	$62.3M
Total Liabilities	$524.6M+14.4%	$458.4M+16.0%	$395.1M+15.1%	$343.4M+18.8%	$289.1M+17.3%	$246.5M+7.2%	$230.0M+43.7%	$160.0M+14.3%	$140.0M+9.6%	$127.8M-6.6%	$136.8M+0.4%	$136.1M+17.1%	$116.2M+15.9%	$100.3M+2.9%	$97.5M
Current Liabilities	$455.9M+13.9%	$400.3M+9.4%	$365.9M+15.9%	$315.6M+26.7%	$249.0M+26.4%	$197.0M+8.5%	$181.6M+25.0%	$145.3M+16.9%	$124.3M+5.6%	$117.6M-7.5%	$127.2M+3.6%	$122.8M+17.9%	$104.2M+14.3%	$91.1M+3.4%	$88.1M
Non-Current Liabilities	$68.7M+18.2%	$58.1M+99.3%	$29.2M+5.0%	$27.8M-30.6%	$40.0M-19.2%	$49.5M+2.3%	$48.4M+228.4%	$14.7M-6.6%	$15.8M+55.8%	$10.1M+5.9%	$9.6M-28.2%	$13.3M+10.6%	$12.1M+31.6%	$9.2M-2.5%	$9.4M
Total Equity	$314.8M+5.2%	$299.1M+7.5%	$278.3M+22.7%	$226.8M-9.5%	$250.6M+14.5%	$218.9M+53.9%	$142.3M-3.3%	$147.1M-15.9%	$175.0M+3.3%	$169.4M-13.4%	$195.5M+7.4%	$182.0M+0.2%	$181.6M+12.4%	$161.5M-0.4%	$162.1M
Retained Earnings	$345.1M+4.8%	$329.4M+8.1%	$304.7M+20.1%	$253.7M-6.0%	$269.8M+14.1%	$236.5M+48.3%	$159.5M-2.4%	$163.4M-12.2%	$186.1M+0.8%	$184.6M-10.9%	$207.1M+8.2%	$191.3M+1.4%	$188.6M+14.0%	$165.4M-0.9%	$167.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$698.6M-6.2%	$740.5M+4.6%	$839.4M+10.8%	$768.8M+10.1%	$744.7M+11.9%	$708.2M+5.0%	$757.6M+12.5%	$698.1M+21.8%
Current Assets	$467.1M-3.4%	$515.8M+13.3%	$583.3M+15.9%	$525.8M+16.2%	$483.3M+13.4%	$455.3M+2.3%	$503.3M+5.0%	$452.3M+15.1%
Cash & Equivalents	$186.1M-19.3%	$226.1M+9.8%	$328.7M+23.5%	$263.6M+22.6%	$230.6M+13.8%	$205.9M-0.8%	$266.2M-1.7%	$215.0M+17.9%
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Accounts Receivable	$218.9M+4.3%	$227.1M+7.8%	$214.7M+4.5%	$219.6M+9.9%	$209.8M+9.7%	$210.7M+2.4%	$205.5M+13.4%	$199.8M+8.9%
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Goodwill	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%	$62.2M0.0%
Total Liabilities	$541.1M+16.1%	$535.4M+15.6%	$524.6M+14.4%	$459.6M+9.4%	$465.9M+9.7%	$463.1M+6.4%	$458.4M+16.0%	$420.2M+15.8%
Current Liabilities	$475.1M+16.7%	$467.4M+15.4%	$455.9M+13.9%	$400.4M+10.5%	$407.2M+12.3%	$405.0M+8.9%	$400.3M+9.4%	$362.2M+8.8%
Non-Current Liabilities	$66.1M+12.5%	$68.0M+17.0%	$68.7M+18.2%	$59.2M+2.2%	$58.8M-5.2%	$58.1M-8.0%	$58.1M+99.3%	$57.9M+92.7%
Total Equity	$157.5M-43.5%	$205.2M-16.3%	$314.8M+5.2%	$309.2M+11.2%	$278.8M+15.8%	$245.1M+2.3%	$299.1M+7.5%	$278.0M+32.3%
Retained Earnings	$193.9M-36.3%	$240.6M-12.2%	$345.1M+4.8%	$338.7M+11.6%	$304.5M+13.7%	$274.1M+2.7%	$329.4M+8.1%	$303.4M+27.3%

Not reported in any period shown, so not listed: Inventory, Long-Term Debt.

MANH Cash Flow Statement

MANH quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$414.9M	$389.5M+32.0%	$295.0M+19.8%	$246.2M+37.1%	$179.6M-3.0%	$185.2M+31.4%	$140.9M-4.1%	$146.9M+7.0%	$137.3M-16.3%	$164.1M+17.7%	$139.3M+16.0%	$120.2M+27.6%	$94.2M+5.3%	$89.4M+18.8%	$75.3M+34.8%	$55.8M
Depreciation & Amortization	N/A	$6.3M+0.3%	$6.3M+9.5%	$5.8M-13.7%	$6.7M-15.8%	$7.9M-11.5%	$8.9M+12.0%	$8.0M-7.3%	$8.6M-4.9%	$9.1M-0.3%	$9.1M+17.1%	$7.8M+21.8%	$6.4M+9.5%	$5.8M+3.3%	$5.6M-22.6%	$7.3M
Stock-Based Compensation	N/A	$111.3M+19.4%	$93.2M+30.2%	$71.6M+20.6%	$59.4M+37.2%	$43.3M+29.7%	$33.4M+4.8%	$31.8M+60.3%	$19.9M+22.4%	$16.2M+1.9%	$15.9M+9.7%	$14.5M+50.2%	$9.7M+32.0%	$7.3M-12.1%	$8.3M-19.6%	$10.4M
Capital Expenditures	$15.7M	$15.5M+78.2%	$8.7M+83.4%	$4.7M-28.2%	$6.6M+64.0%	$4.0M+47.1%	$2.7M-82.0%	$15.2M+108.0%	$7.3M+17.9%	$6.2M-9.4%	$6.8M-40.5%	$11.5M+22.1%	$9.4M+98.6%	$4.7M-39.8%	$7.9M+55.2%	$5.1M
Free Cash Flow	$399.2M	$374.0M+30.6%	$286.3M+18.6%	$241.5M+39.6%	$173.0M-4.5%	$181.2M+31.1%	$138.2M+4.9%	$131.7M+1.3%	$130.0M-17.6%	$157.9M+19.1%	$132.5M+21.9%	$108.7M+28.2%	$84.7M+0.1%	$84.6M+25.6%	$67.4M+32.8%	$50.8M
Investing Cash Flow	-$15.7M	-$15.5Mn/m	-$8.7Mn/m	-$4.7Mn/m	-$6.6Mn/m	-$4.0Mn/m	-$2.7Mn/m	-$13.8Mn/m	-$9.8Mn/m	-$5.8M-271.8%	$3.4M	N/A	N/A	-$7.8Mn/m	-$7.0Mn/m	-$4.6M
Financing Cash Flow	-$435.0M	-$315.2Mn/m	-$286.4Mn/m	-$196.0Mn/m	-$204.5Mn/m	-$120.4Mn/m	-$43.6Mn/m	-$121.5Mn/m	-$149.3Mn/m	-$131.7Mn/m	-$162.7M	N/A	N/A	-$51.8Mn/m	-$63.5Mn/m	-$77.9M
Share Buybacks	$435.0M	$315.2M+10.1%	$286.4M+46.1%	$196.0M-4.1%	$204.5M+69.8%	$120.4M+176.4%	$43.6M-64.1%	$121.5M-18.6%	$149.3M+13.4%	$131.7M-21.6%	$167.9M+49.8%	$112.1M+13.0%	$99.2M+54.5%	$64.2M-37.8%	$103.2M-22.5%	$133.1M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$90.7M+22.5%	$84.0M+11.7%	$147.1M+40.4%	$93.1M+49.5%	$74.0M+1.1%	$75.3M+37.5%	$104.7M+18.5%	$62.3M+6.4%
Depreciation & Amortization	$1.6M+3.0%	$1.8M+18.9%	$1.5M-6.1%	$1.7M-1.7%	$1.6M+6.4%	$1.5M+3.2%	$1.6M+8.4%	$1.7M+17.2%
Stock-Based Compensation	N/A	$26.5M-8.0%	N/A	N/A	N/A	$28.8M+30.5%	N/A	N/A
Capital Expenditures	$1.0M-74.7%	$4.1M+360.5%	$4.7M+48.9%	$5.9M+487.5%	$4.0M+79.5%	$891K-61.6%	$3.1M+58.9%	$1.0M-7.1%
Free Cash Flow	$89.7M+28.0%	$79.9M+7.5%	$142.4M+40.2%	$87.2M+42.2%	$70.1M-1.4%	$74.4M+41.9%	$101.6M+17.6%	$61.3M+6.6%
Investing Cash Flow	-$1.0Mn/m	-$4.1Mn/m	-$4.7Mn/m	-$5.9Mn/m	-$4.0Mn/m	-$891Kn/m	-$3.1Mn/m	-$1.0Mn/m
Financing Cash Flow	-$127.1Mn/m	-$179.4Mn/m	-$77.0Mn/m	-$51.5Mn/m	-$50.2Mn/m	-$136.4Mn/m	-$45.2Mn/m	-$51.6Mn/m
Share Buybacks	$127.1M+153.2%	$179.4M+31.5%	$77.0M+70.2%	$51.5M-0.1%	$50.2M-33.7%	$136.4M+19.9%	$45.2M+13560.4%	$51.6M+94.0%

Not reported in any period shown, so not listed: Dividends Paid.

MANH Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MANH quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	56.3%+1.5pp	54.8%+1.2pp	53.6%+0.3pp	53.3%-1.8pp	55.1%+1.2pp	54.0%+0.1pp	53.9%-3.0pp	56.9%-1.7pp	58.7%0.0pp	58.7%+138.0pp	-79.3%-21.4pp	-57.9%+5.6pp	-63.5%-8.6pp	-54.9%-1.6pp	-53.4%
Operating Margin	25.9%+0.8pp	25.1%+2.5pp	22.6%+2.7pp	19.9%-0.3pp	20.2%+0.8pp	19.4%+0.7pp	18.8%-5.2pp	23.9%-7.3pp	31.2%-0.9pp	32.1%	123.0%	94.5%+3.0pp	91.4%+14.7pp	76.7%+9.1pp	67.7%
Net Margin	20.3%-0.6pp	20.9%+1.9pp	19.0%+2.2pp	16.8%+0.2pp	16.7%+1.8pp	14.9%+1.0pp	13.9%-4.8pp	18.7%-0.9pp	19.6%-1.0pp	20.5%-58.3pp	78.8%+17.9pp	60.9%+0.2pp	60.7%+11.1pp	49.7%+0.2pp	49.5%
Return on Equity	69.9%-3.1pp	73.0%+9.6pp	63.4%+6.6pp	56.9%+12.8pp	44.1%+4.2pp	39.9%-20.4pp	60.3%-10.9pp	71.2%+4.6pp	66.6%-6.8pp	73.4%+20.4pp	52.9%+7.9pp	45.1%+8.0pp	37.1%+4.9pp	32.1%+4.4pp	27.7%
Return on Assets	26.2%-2.6pp	28.8%+2.6pp	26.2%+3.6pp	22.6%+2.2pp	20.5%+1.7pp	18.7%-4.3pp	23.0%-11.0pp	34.1%-2.9pp	37.0%-4.8pp	41.8%+10.7pp	31.1%+5.4pp	25.8%+3.2pp	22.6%+2.8pp	19.8%+2.5pp	17.3%
Current Ratio	1.280.0x	1.26-0.1x	1.310.0x	1.32-0.3x	1.64-0.1x	1.70+0.4x	1.28-0.2x	1.48-0.4x	1.84+0.1x	1.76-0.1x	1.860.0x	1.87-0.2x	2.10+0.1x	1.990.0x	1.98
Liabilities-to-Equity	1.67+0.1x	1.53+0.1x	1.42-0.1x	1.51+0.4x	1.150.0x	1.13-0.5x	1.62+0.5x	1.09+0.3x	0.800.0x	0.75+0.1x	0.700.0x	0.75+0.1x	0.640.0x	0.620.0x	0.60
Asset Turnover	1.29-0.1x	1.380.0x	1.380.0x	1.35+0.1x	1.230.0x	1.26-0.4x	1.66-0.2x	1.82-0.1x	1.89-0.1x	2.03+1.6x	0.400.0x	0.42+0.1x	0.370.0x	0.400.0x	0.35
FCF Margin	34.6%+7.1pp	27.5%+1.5pp	26.0%+3.4pp	22.6%-4.7pp	27.3%+3.7pp	23.6%+2.2pp	21.3%-1.9pp	23.3%-3.3pp	26.6%+4.6pp	21.9%-60.8pp	82.8%+19.8pp	63.0%-13.4pp	76.4%+11.8pp	64.6%+8.6pp	56.0%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	56.5%-0.8pp	55.1%-1.3pp	55.0%-0.9pp	56.6%+1.1pp	57.3%+2.6pp	56.4%+3.3pp	55.8%+0.6pp	55.5%+2.2pp
Operating Margin	22.2%-4.8pp	23.0%-1.0pp	24.8%+1.1pp	27.5%-0.7pp	27.1%+1.4pp	24.0%+1.4pp	23.7%-1.0pp	28.2%+5.7pp
Net Margin	16.9%-3.9pp	17.5%-2.5pp	19.2%+0.4pp	21.3%-2.7pp	20.8%+1.0pp	20.0%-1.1pp	18.8%-1.7pp	23.9%+3.2pp
Return on Equity	32.0%+11.6pp	24.0%+2.6pp	16.5%+0.5pp	19.0%-4.0pp	20.4%-1.6pp	21.4%-1.0pp	16.1%-1.5pp	22.9%-0.6pp
Return on Assets	7.2%-0.4pp	6.7%-0.8pp	6.2%-0.2pp	7.6%-1.5pp	7.6%-0.3pp	7.4%-0.5pp	6.3%-0.9pp	9.1%+0.5pp
Current Ratio	0.98-0.2x	1.100.0x	1.280.0x	1.31+0.1x	1.190.0x	1.12-0.1x	1.26-0.1x	1.25+0.1x
Liabilities-to-Equity	3.44+1.8x	2.61+0.7x	1.67+0.1x	1.490.0x	1.67-0.1x	1.89+0.1x	1.53+0.1x	1.51-0.2x
Asset Turnover	0.43+0.1x	0.380.0x	0.320.0x	0.360.0x	0.370.0x	0.370.0x	0.340.0x	0.380.0x
FCF Margin	30.1%+4.4pp	28.3%0.0pp	52.7%+12.9pp	31.6%+8.6pp	25.7%-1.1pp	28.3%+7.7pp	39.7%+3.5pp	23.0%-1.1pp

Not reported in any period shown, so not listed: Debt-to-Equity.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Manhattan Associates Inc MANH	FY2025	$1.1B	$219.9M	20.3%	$13.8B	67/100
PAYCOM SOFTWARE, INC. PAYC	FY2025	$2.1B	$453.4M	22.1%	$12.1B	62/100
Full Truck Alliance Co. Ltd. YMM	FY2025	$1.8B	$637.6M	35.7%	$8.7B	77/100
Dynatrace, Inc. DT	FY2026	$2.0B	$162.7M	8.1%	$18.6B	66/100
AppFolio, Inc. APPF	FY2025	$950.8M	$140.9M	14.8%	$7.6B	74/100
Bentley Systems, Incorporated BSY	FY2025	$1.5B	$277.9M	18.5%	$12.0B	61/100

Where Manhattan Associates Inc Ranks

Frequently Asked Questions

What is Manhattan Associates Inc's annual revenue?

Manhattan Associates Inc (MANH) reported $1.1B in total revenue for fiscal year 2025. This represents a 3.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Manhattan Associates Inc's revenue growing?

Manhattan Associates Inc (MANH) revenue grew by 3.7% year-over-year, from $1.0B to $1.1B in fiscal year 2025.

Is Manhattan Associates Inc profitable?

Yes, Manhattan Associates Inc (MANH) reported a net income of $210.2M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net income of $219.9M, with a net profit margin of 20.3%.

What is Manhattan Associates Inc's EBITDA?

Manhattan Associates Inc (MANH) had EBITDA of $286.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Manhattan Associates Inc's gross margin?

Manhattan Associates Inc (MANH) had a gross margin of 56.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Manhattan Associates Inc's operating margin?

Manhattan Associates Inc (MANH) had an operating margin of 25.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Manhattan Associates Inc's net profit margin?

Manhattan Associates Inc (MANH) had a net profit margin of 20.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Manhattan Associates Inc's return on equity (ROE)?

Manhattan Associates Inc (MANH) has a return on equity of 69.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Manhattan Associates Inc's free cash flow?

Manhattan Associates Inc (MANH) generated $374.0M in free cash flow during fiscal year 2025. This represents a 30.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Manhattan Associates Inc's operating cash flow?

Manhattan Associates Inc (MANH) generated $389.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Manhattan Associates Inc's total assets?

Manhattan Associates Inc (MANH) had $839.4M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Manhattan Associates Inc's capital expenditures?

Manhattan Associates Inc (MANH) invested $15.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Manhattan Associates Inc spend on research and development?

Manhattan Associates Inc (MANH) invested $145.1M in research and development during fiscal year 2025.

Does Manhattan Associates Inc buy back shares?

Yes, Manhattan Associates Inc (MANH) spent $315.2M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Manhattan Associates Inc have outstanding?

Manhattan Associates Inc (MANH) had 60M shares outstanding as of fiscal year 2025.

What is Manhattan Associates Inc's current ratio?

Manhattan Associates Inc (MANH) had a current ratio of 1.28 as of fiscal year 2025, which is considered adequate.

What is Manhattan Associates Inc's liabilities-to-equity ratio?

Manhattan Associates Inc (MANH) had a liabilities-to-equity ratio of 1.67 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

What is Manhattan Associates Inc's return on assets (ROA)?

Manhattan Associates Inc (MANH) had a return on assets of 26.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Manhattan Associates Inc's P/E ratio?

Manhattan Associates Inc (MANH) trades at 65.6x earnings, its market capitalization divided by $210.2M net income, trailing 12 months to June 30, 2026. The market capitalization is $13.8B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Manhattan Associates Inc's price-to-sales ratio?

Manhattan Associates Inc (MANH) trades at 12.2x sales, its market capitalization divided by $1.1B revenue, trailing 12 months to June 30, 2026. The market capitalization is $13.8B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Manhattan Associates Inc's Altman Z-Score?

Manhattan Associates Inc (MANH) has an Altman Z-Score of 18.91, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Manhattan Associates Inc's Piotroski F-Score?

Manhattan Associates Inc (MANH) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Manhattan Associates Inc's earnings high quality?

Manhattan Associates Inc (MANH) has an earnings quality ratio of 1.77x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Manhattan Associates Inc?

Manhattan Associates Inc (MANH) scores 67 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.